GE HealthCare Technologies Inc. (NASDAQ:GEHC) Stock Position Lowered by Adage Capital Partners GP L.L.C.

Adage Capital Partners GP L.L.C. decreased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 58.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 230,328 shares of the company's stock after selling 325,172 shares during the period. Adage Capital Partners GP L.L.C. owned about 0.05% of GE HealthCare Technologies worth $18,007,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Syon Capital LLC increased its holdings in shares of GE HealthCare Technologies by 16.1% in the 4th quarter. Syon Capital LLC now owns 3,172 shares of the company's stock valued at $248,000 after purchasing an additional 440 shares during the period. T. Rowe Price Investment Management Inc. grew its position in GE HealthCare Technologies by 0.9% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 3,002,648 shares of the company's stock valued at $234,748,000 after purchasing an additional 26,395 shares in the last quarter. Dark Forest Capital Management LP increased its stake in GE HealthCare Technologies by 154.4% in the 4th quarter. Dark Forest Capital Management LP now owns 7,343 shares of the company's stock valued at $574,000 after buying an additional 4,457 shares during the period. Hsbc Holdings PLC lifted its position in GE HealthCare Technologies by 10.4% in the 4th quarter. Hsbc Holdings PLC now owns 882,280 shares of the company's stock worth $69,022,000 after buying an additional 82,973 shares in the last quarter. Finally, Fayez Sarofim & Co boosted its stake in shares of GE HealthCare Technologies by 7.3% during the 4th quarter. Fayez Sarofim & Co now owns 9,150 shares of the company's stock valued at $715,000 after buying an additional 625 shares during the period. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Up 2.0 %

Shares of NASDAQ:GEHC opened at $68.42 on Friday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The stock's 50-day moving average is $76.59 and its 200-day moving average is $82.13. The company has a market cap of $31.33 billion, a P/E ratio of 15.80, a P/E/G ratio of 3.19 and a beta of 1.14. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.19. The firm had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. Equities research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be given a $0.035 dividend. The ex-dividend date is Friday, April 25th. This represents a $0.14 annualized dividend and a yield of 0.20%. GE HealthCare Technologies's dividend payout ratio is 3.23%.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on GEHC. Wells Fargo & Company upped their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a research note on Friday, February 14th. Jefferies Financial Group raised GE HealthCare Technologies from a "hold" rating to a "buy" rating and upped their target price for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. The Goldman Sachs Group upgraded GE HealthCare Technologies from a "neutral" rating to a "buy" rating and lifted their price target for the company from $85.00 to $100.00 in a report on Tuesday, March 11th. Piper Sandler dropped their price objective on GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating on the stock in a report on Wednesday. Finally, Citigroup lifted their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research note on Thursday, February 13th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, nine have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $96.50.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.